Disease: Prolymphocytic leukemia
- <em>De-Novo</em> B-Cell Prolymphocytic Leukemia
- A particular presentation of a T cell large granular lymphocytic leukaemia
- A phase 1 study to evaluate the safety, pharmacology, and feasibility of continuous infusion nelarabine in patients with relapsed and/or refractory lymphoid malignancies
- Acalabrutinib monotherapy for treatment of chronic lymphocytic leukaemia (ACE-CL-001): analysis of the Richter transformation cohort of an open-label, single-arm, phase 1-2 study
- Acute visual change as first symptom of B-cell prolymphocytic leukaemia
- Advanced Pathogenetic Concepts in T-Cell Prolymphocytic Leukemia and Their Translational Impact
- Advances in Cellular Therapy for T-Cell Prolymphocytic Leukemia
- AGO2 in T-prolymphocytic leukemia: its canonical and non-canonical deregulation and function
- An unusual case of T-cell prolymphocytic leukemia mimicking a cutaneous vasculitis
- Anterior Chamber Cytology Confirms the Diagnosis of T-cell Prolymphocytic Leukemia Masquerading as Viral Retinal Necrosis
- Autologous hematopoietic cell transplantation for T-cell prolymphocytic leukemia: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT
- B-cell lymphoma-2 downregulation is a useful feature supporting a neoplastic phenotype in mature T-cell lymphomas
- B-cell prolymphocytic leukemia after COVID-19 infection
- B-cell prolymphocytic leukemia with P53 abnormalities successfully treated with bendamustine and rituximab: a report of three cases
- B-prolymphocytic leukemia (B-PLL) with genetic aberrations involving <em>MYC</em> and <em>TP53</em>
- B-prolymphocytic leukemia (B-PLL) with genetic aberrations involving MYC and TP53
- B-prolymphocytic leukemia: Is it time to retire this entity?
- Case report: CD8 positive T-cell Prolymphocytic Leukemia presenting complex karyotype with a rare chromosomal abnormality der(2)t(1;2)(q21;q37) and additional signals of the genes MYC, IGH, and TP53
- Characteristics and survival outcomes of patients with T cell prolymphocytic leukemia in the United States: 2011-2020 analysis of the SEER database
- Chronic lymphocytic leukaemia/small lymphocytic lymphoma and mantle cell lymphoma: from early lesions to transformation
- CircBCAR3 sponges miR-27a-3p and mediates ferroptosis in human B-prolymphocytic leukaemia cells via SLC7A11
- Circulating Monocytes Phagocytosing Lymphocytes in Small-cell Variant of T-cell Prolymphocytic Leukemia
- Circulating Monocytes Phagocytosing Lymphocytes in the Small-Cell Variant of T-Cell Prolymphocytic Leukemia
- Classification of indolent B-cell lymphomas : Novelties and open questions
- Clinical analysis of prolymphoblastic leukemia: the rare hematological malignancy in the elderly
- Clinical Characteristics of Aggressive NK-Cell Leukemia
- Clinical features and prognosis of eight patients with splenic diffuse red pulp small B-cell lymphoma
- Computational gene expression analysis reveals distinct molecular subgroups of T-cell prolymphocytic leukemia
- Critical Role of Flow Cytometric Immunophenotyping in the Diagnosis, Subtyping, and Staging of T-Cell/NK-Cell Non-Hodgkin's Lymphoma in Real-World Practice: A Study of 232 Cases From a Tertiary Cancer Center in India
- Cytogenetics in the management of mature T-cell and NK-cell neoplasms: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH)
- De novo chronic lymphocytic leukemia/prolymphocytic leukemia or B-cell prolymphocytic leukemia? The importance of integrating clinico-morphological and immunophenotypic findings in distinguishing chronic lymphoproliferative diseases with circulating phase
- De-Novo B-Cell Prolymphocytic Leukemia
- Delayed Diagnosis of T-Cell Prolymphocytic Leukemia: Approach to Chronic Lymphocytosis
- Delineation of clinical course, outcomes, and prognostic factors in patients with T-cell prolymphocytic leukemia
- Development of HDAC Inhibitors Exhibiting Therapeutic Potential in T-Cell Prolymphocytic Leukemia
- Disseminated Mycobacterium haemophilum infection during alemtuzumab treatment of T-cell prolymphocytic leukemia
- Durable remission of T-cell prolymphocytic leukemia with CLEC16A::IL2 after allogeneic hematopoietic stem cell transplantation
- EBV-positive diffuse large B-cell lymphoma following alemtuzumab therapy for T-cell prolymphocytic leukemia
- Editorial: Pathogenesis, treatment, and future directions for rare T-cell leukemias
- Exploration of whole genome and transcriptome sequencing data lacks evidence for oncogenic viral elements to drive the pathogenesis of T-cell prolymphocytic leukemia
- Expression pattern and diagnostic utility of BCL11B in mature T- and NK-cell neoplasms
- From the archives of MD Anderson Cancer Center: Aleukemic T-prolymphocytic leukemia, a rare presentation and review of the literature
- Guidelines for the management of mature T- and natural killer-cell lymphomas (excluding cutaneous T-cell lymphoma): a British Society for Haematology Guideline
- Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide for T-Cell Prolymphocytic Leukemia after Alemtuzumab Induction Therapy: A Case Report
- Inactive T-cell prolymphocytic leukemia with negative surface CD3: Cytogenetic pitfalls
- Incidental but rapidly progressing T-cell prolymphocytic leukemia with t(X;14)(q28;q11) involving parotid lymphoepithelial cysts: A diagnostic pitfall
- Intramural esophageal hematoma precipitated by acquired factor XI deficiency in a patient with relapsed T cell prolymphocytic leukemia after allogeneic hematopoietic cell transplantation
- KLRG1 Cell Depletion As A Novel Therapeutic Strategy In Patients With Mature T-cell lymphoma Subtypes
- Leonine facies: A unique presentation of T-prolymphocytic leukemia
- Leukemia Cutis
- Leukemia Cutis
- Limited efficacy for ibrutinib and venetoclax in T-prolymphocytic leukemia: results from a phase 2 international study
- Long-Smoldering T-prolymphocytic Leukemia: A Case Report and a Review of the Literature
- Lymphoid blood cancers, incidence and survival 2005-2023: A report from the UK's Haematological Malignancy Research Network
- Lymphoproliferative Disorders
- Lymphoproliferative Disorders
- Mature T-Cell leukemias: Challenges in Diagnosis
- Molecular characterization of Novel <em>ATM</em> fusions in chronic lymphocytic leukemia and T-cell prolymphocytic leukemia
- Molecular characterization of Novel ATM fusions in chronic lymphocytic leukemia and T-cell prolymphocytic leukemia
- Mycobacterial Spindle Cell Pseudotumor of the Nasal Cavity
- Non-Hodgkin lymphoma mimicking acute leukemia: a report of six cases and review of the literature
- Noncanonical Function of AGO2 Augments T-cell Receptor Signaling in T-cell Prolymphocytic Leukemia
- Obituary for a diagnosis: B-cell prolymphocytic leukaemia (1974-2022)
- Outcomes of Allogeneic Hematopoietic Cell Transplantation in T Cell Prolymphocytic Leukemia: A Contemporary Analysis from the Center for International Blood and Marrow Transplant Research
- Partial response to venetoclax and ruxolitinib combination in a case of refractory T-prolymphocytic leukemia
- Possible Tacrolimus-Related Neuropsychiatric Symptoms: One Year After Allogeneic Hematopoietic Cell Transplantation: A Case Report
- Progression and transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma and B-cell prolymphocytic leukemia: Report from the 2021 SH/EAHP Workshop
- Prolymphocytic Leukaemia: an Update on Biology and Treatment
- Recurrence of T-Cell Prolymphocytic Leukemia With a Rare Presentation as Diffuse Generalized Skin Lesion
- Relapsed B-cell prolymphocytic leukemia (B-PLL) with distinctive granular inclusion bodies
- Research Advances of Genetics, Diagnosis and Treatment of T-cell Prolymphocytic Leukemia--Review
- Retrospective analysis of a cohort of 41 <em>de novo</em> B-cell prolymphocytic leukemia patients: impact of genetics and targeted therapies (a FILO study)
- Retrospective analysis of a cohort of 41 de novo B-cell prolymphocytic leukemia patients: impact of genetics and targeted therapies (a FILO study)
- RNASeq Analysis for Accurate Identification of Fusion Partners in Tumor Specific Translocations Detected by Standard FISH Probes in Hematologic Malignancies
- Small cell variant anaplastic large cell lymphoma presenting as leukemia: A case report and review of Literature
- Sunsetting B-prolymphocytic leukemia
- Sustained MRD negative remission in del17p and TP53 mutated B cell prolymphocytic leukemia with ibrutinib and venetoclax
- T-cell prolymphocytic leukaemia associated with immune checkpoint inhibitor (pembrolizumab)
- T-Cell Prolymphocytic Leukemia
- T-Cell Prolymphocytic Leukemia
- T-cell prolymphocytic leukemia is associated with deregulation of oncogenic microRNAs on transcriptional and epigenetic level
- T-cell prolymphocytic leukemia with follicular mucinosis
- T-cell prolymphocytic leukemia with lung involvement presenting as crazy paving on high-resolution computed tomography
- T-Cell Prolymphocytic Leukemia With t(X;14)(q28;q11.2): A Clinicopathologic Study of 15 Cases
- T-cell prolymphocytic leukemia, cerebriform variant
- T-Cell Prolymphocytic Leukemia: Diagnosis, Pathogenesis, and Treatment
- T-cell prolymphocytic leukemia: Epidemiology and survival trends in the era of novel treatments
- T-cell prolymphocytic leukemia/lymphoma with TCRB::TCL1 translocation
- T-prolymphocytic leukaemia with sezary-like morphology
- T-prolymphocytic leukemia: TCL1 or MTCP1 rearrangement is not mandatory to establish diagnosis
- Targeting iron import to treat ANKL
- The fifth edition of the WHO classification of mature B-cell neoplasms: open questions for research
- The hepatic niche leads to aggressive natural killer cell leukemia proliferation through the transferrin-transferrin receptor 1 axis
- The miR-141/200c-STAT4 Axis Contributes to Leukemogenesis by Enhancing Cell Proliferation in T-PLL
- Therapeutic leukocytapheresis for leukostasis in chronic lymphocytic leukemia: A case report and literature review
- Untangling hairy cell leukaemia (HCL) variant and other HCL-like disorders: Diagnosis and treatment
- Venetoclax induces deep and durable minimal residual disease-negative remission in high-risk TP53 disrupted B prolymphocytic leukaemia
- Zanubrutinib (Brukinsa): CADTH Reimbursement Recommendation: Indication: For the treatment of adult patients with chronic lymphocytic leukemia
- Zanubrutinib (Brukinsa): CADTH Reimbursement Recommendation: Indication: For the treatment of adult patients with chronic lymphocytic leukemia [Internet]
- Zanubrutinib, rituximab and lenalidomide induces deep and durable remission in TP53-mutated B-cell prolymphocytic leukemia: a case report and literature review